Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
-6.0%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 43.81% |
| 2024 | 6.98% |
| 2023 | -10.07% |
| 2022 | 52.66% |
| 2021 | -6.52% |
| 2020 | -17.61% |
| 2019 | 29.51% |
| 2018 | -2.80% |
| 2017 | 25.42% |
| 2016 | 59.37% |